Vivimed Labs Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on December 10, 2025
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivimed Labs Limited has filed the proceedings of its Extraordinary General Meeting held on December 10, 2025 with the stock exchange, as part of standard listing compliance requirements. The specific resolutions passed at the meeting are not detailed in the headline. Shareholders typically receive a detailed report within the regulatory filing window. The full voting results and resolution details would be available in the attached document submitted to the exchange.
The filing is a routine disclosure and does not itself indicate any price-moving development. Investors should review the detailed EGM voting results to understand any corporate actions approved, such as capital raising, restructuring, or other significant proposals that could affect shareholding or business direction.